Skip to content

Treatment of Headache with Unani Medicine Itrifal Mulayyan

Clinical Validation of Unani Pharmacopoeal formulation Itrifal Mulayyan in Suda (Headache)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015450
Enrollment
240
Registered
2018-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R51- Headache Health Condition 2: null- Suda (Headache)

Interventions

Intervention1: Itrifal Mulayyan: Itrifal Mulayyan, 7gm Orally once a day at bed time for a period of one week Control Intervention1: Nil: Nil

Sponsors

Central Council For Research In Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex with age 18-65 years 2. Patients having SudÄ?â?? (Headache) with or without any of the following symptoms: Disturbed concentration Irritability Zuâ??f al-IshtihÄ?â?? (Decreased appetite) Iâ??yÄ? (Fatigue) Difficulty in falling asleep and staying asleep Mild sensitivity to light/ noise

Exclusion criteria

Exclusion criteria: 1. Headache accompanied by impaired neurological functions (loss of balance, weakness, numbness, or speech disturbances), double vision, seizures, mental disturbances, and loss of consciousness. 2. Headache accompanied by persistent nausea, vomiting, fever and stiff neck 3. History of recent head injury. 4. Known cases of any other acute illness. 5. Known cases of severe Renal/ Hepatic/ Cardiac ailments 6. Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Improvement in the sign and symptoms of Suda (Headache)Timepoint: One Week

Secondary

MeasureTime frame
Hematological and biochemical assessments for safetyTimepoint: one week

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026